Delivery Order SPE2DR25D1106-SPE2DR26FJD4G
- Not listed
- The Defense Logistics Agency awarded a $22,446.15 delivery order to AmerisourceBergen Drug Corp for the supply of Naltrexone 50 mg tablets in quantities of 60 units. This is a firm fixed-price, non-set-aside contract with an ultimate completion date of December 9, 2025. AmerisourceBergen will fulfill this order from its corporate office location in Conshohocken, Pennsylvania, where the company maintains its primary pharmaceutical distribution operations. This delivery order is issued under...
- The Defense Logistics Agency awarded a delivery order valued at $47,260.15 to AmerisourceBergen Drug Corp for the supply of Naltrexone 50 mg tablets in quantities of 60 units. The contract, executed on August 5, 2025, with an ultimate completion date of August 6, 2025, utilizes firm fixed pricing with no set-aside designation, indicating competitive award. Performance will occur at the vendor's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a child...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Naltrexone 50 mg tablets (100-count units) with a contract ceiling value of $3,908.57. This is a firm fixed-price delivery order with an ultimate completion date of December 12, 2025, awarded on December 11, 2025, with no set-aside designation. The award represents a competitive procurement under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Naltrexone 50 mg tablets in 30-count packages, with a contract ceiling value of $1,760.25. The award, issued on December 8, 2025, represents a firm fixed-price delivery order with an ultimate completion date of December 9, 2025. This non-competitive set-aside contract leverages AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated as...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $40,872.08 to AmerisourceBergen Drug Corp for the supply of Naltrexone 50 mg tablets in quantities of 60 units. The contract, awarded on July 30, 2025, with an ultimate completion date of July 31, 2025, represents a firm fixed-price delivery order with no set-aside designation. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, fulfilled this order through its Corporate Office division and performed work...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on October 30, 2025, for the supply of Naltrexone 50 mg tablets (100-count units) with a contract ceiling value of $1,700.58. This firm fixed-price delivery order, which is set to be completed by October 31, 2025, represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999 through December 2026. The award was...
- The Defense Logistics Agency awarded a $3,524.80 delivery order to AmerisourceBergen Drug Corp on November 3, 2025, for the supply of Naltrexone 50 mg tablets (60-count units), with completion scheduled for November 4, 2025. This firm fixed-price contract was competitively awarded with no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award represents a child delivery order under AmerisourceBergen's larger...
- AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, received a delivery order valued at $2,295.42 from the Defense Logistics Agency (DLA) for Naltrexone 50 mg tablets in quantities of 60, with an ultimate completion date of July 31, 2025. This firm fixed-price contract was competitively awarded without set-aside provisions and represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $22,997.98 for Naltrexone 50 mg tablets (60-count) on January 29, 2025, with completion expected by January 30, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and is being performed at the contractor's facility in Conshohocken, Pennsylvania. The award represents a continuation of AmerisourceBergen's role as a critical pharmaceutical supplier to the...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Naltrexone 50mg tablets (30-count) under a firm fixed-price contract valued at $4,781. The award was made on December 4, 2025, with an ultimate completion date of January 2, 2026. This non-competitive delivery order will be fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company maintains its headquarters and primary pharmaceutical...
- SPE2DR25D1106Indefinite Delivery Contract
- SPE2DR25D1106-SPE2DR26FJD4GDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $12,265.43 to AmerisourceBergen Drug Corp for the supply of Naltrexone 50 mg tablets (60-count) with a completion deadline of December 12, 2025. This competitively awarded, firm fixed-price contract with no set-aside designation leverages AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $999.99 billion prime vendor agreement running through December 2026. The contractor, headquartered in Conshohocken, Pennsylvania, serves as a critical pharmaceutical distributor for federal military and veteran healthcare systems. AmerisourceBergen's federal contracting profile demonstrates extensive experience fulfilling DLA medical supply requirements across a broad portfolio of pharmaceutical products, including specialty medications, generic drugs, vaccines, and medical devices serving multiple therapeutic domains. The company's competitively awarded delivery orders under the SPE2DX vehicle typically utilize firm fixed pricing structures and range from small-value transactions to orders exceeding $45,000, reflecting its capability to meet diverse federal procurement needs. This award supports ongoing pharmaceutical supply requirements for Defense Health Agency and other federal healthcare programs as part of DLA's comprehensive global pharmaceutical support mission.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $12.3k | 12/10/25 |